NCT01977859View on ClinicalTrials.gov

BNP Pharmacodynamics and Effects on Metabolism in Lean and Obese Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

4

Participants

Timeline

Start Date

November 30, 2013

Primary Completion Date

February 15, 2016

Study Completion Date

February 28, 2017

Conditions
ObesityCardiovascular DiseaseHypertensionDiabetes
Interventions
DRUG

Nesiritide

DRUG

Saline

Trial Locations (1)

32804

Translational Research Institute for Metabolism and Diabetes, Orlando

All Listed Sponsors
collaborator

Sanford-Burnham Medical Research Institute

OTHER

lead

AdventHealth Translational Research Institute

OTHER

NCT01977859 - BNP Pharmacodynamics and Effects on Metabolism in Lean and Obese Subjects | Biotech Hunter | Biotech Hunter